title: Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats.
abstract: Antidiuresis and renal diseases alter the levels of guanidino compounds (GCs) in various tissues. Therefore, we hypothesized that diuresis could also disturb GC metabolism, storage, and elimination. In this study, rats were made diuretic to analyze GC levels in plasma, urine, and kidneys. Furosemide was chosen because of its wide use in various human pathologies. Rats were injected intraperitoneally 5 or 10 mg furosemide spread over a 24-hour cycle. Urine was collected over a period of 24 hours before and during furosemide treatment. Plasma was obtained from arterial blood. Renal zones were dissected. The GCs were determined by liquid chromatography. Five milligrams of furosemide provoked a significant increase in plasma and urine levels of GCs compared with those of the controls. The renal distribution and content of GCs were weakly modified by furosemide except for methylguanidine (MG). The level of MG was enhanced by 10 to 16 times in all renal zones. The MG level was 60% higher in renal zones of rats treated with 10 rather than 5 mg furosemide. The fractional excretion of MG was decreased by furosemide. Our data suggest that MG accumulation in kidney and plasma was caused by furosemide, which might induce MG synthesis, and that MG washout from tissue cells into urine by furosemide through the kidney may cause an increase in MG in the kidney.
authors.affiliation: Université Claude Bernard Lyon I, Physiologie Intégrative, Cellulaire et Moléculaire, UMR 5123 CNRS, Bâtiment. R. Dubois, Bvd. du 11 Novembre 1918, F-69622 Villeurbanne Cedex, France. olivier.levillain@univ-lyon1.fr
authors.forename: Olivier
authors.initials: O
authors.lastname: Levillain
authors.forename: Bart
authors.initials: B
authors.lastname: Marescau
authors.forename: Ilse
authors.initials: I
authors.lastname: Possemiers
authors.forename: Peter Paul
authors.initials: PP
authors.lastname: De Deyn
mesh_terms: D000818:Animals; D003404:Creatinine / Q000032:analysis / Q000097:blood / Q000652:urine; D004232:Diuretics / Q000494:pharmacology*; D005665:Furosemide / Q000494:pharmacology*; D006146:Guanidines / Q000032:analysis / Q000097:blood / Q000652:urine; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008760:Methylguanidine / Q000378:metabolism*; D011422:Propionates / Q000032:analysis / Q000097:blood / Q000652:urine; D051381:Rats; D017207:Rats, Sprague-Dawley; D013386:Succinates / Q000032:analysis / Q000097:blood / Q000652:urine
chemical_list: D004232:Diuretics; D006146:Guanidines; D011422:Propionates; D013386:Succinates; C022249:alpha-keto-delta-guanidinovaleric acid; D008760:Methylguanidine; C001318:guanidinosuccinic acid; D005665:Furosemide; D003404:Creatinine; C005775:guanidinopropionic acid